EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Semaphorin3A Rewires CD4+ T-Cell Metabolism via AKT/mTORC1 Inhibition in Health and Rheumatoid Arthritis

Raeda Mubariki, Nasren Eiza, Adi D Sabag, Shiri Keret, Doron Rimar, Gleb Slobodin, Devy Zisman iD, Elias Toubi, Zahava Vadasz

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262211160 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Raeda Mubariki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Proteomic Unit, Bnai Zion Medical Center, Haifa 3478403, Israel. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Semaphorin-3A, Mechanistic Target of Rapamycin Complex 1, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Semaphorin3A (Sema3A) is a regulatory protein found to be expressed on regulatory T and B cells and also secreted into peripheral blood. It has been identified as a potent immune regulator; however, not all its regulatory mechanisms have been evaluated. In this respect, we aim to investigate how Sema3A affects key metabolic pathways in T cells during homeostasis and rheumatoid arthritis (RA), and on the AKT/mTORC1 signaling axis. In this study, peripheral blood samples were collected from 119 healthy donors and 32 rheumatoid arthritis patients. T cells were subjected to Seahorse analysis to evaluate OXPHOS and glycolysis, live cell TMRE staining to evaluate mitochondrial activity, mass spectrometry for metabolite profiling, ATP determination to study ATP production, and Western blot analysis to investigate the signaling pathway activity. This study presents evidence showing that Sema3A inhibits the AKT/mTORC1 pathway, leading to a decreased glucose uptake and glycolysis disruption. Furthermore, we show that Sema3A reduces mitochondrial capacity and OXPHOS in activated T cells of healthy and RA donors, leading to a decreased ATP production. In contrast, Sema3A upregulates fatty acid oxidation (FA), probably as a backup pathway to ensure cell survival. Results with p values of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidSemaphorin-3AMechanistic Target of Rapamycin Complex 1Proto-Oncogene Proteins c-aktCD4-Positive T-LymphocytesHumansFemaleMaleMiddle AgedGlycolysisSignal TransductionMitochondriaOxidative PhosphorylationAdultAged

Stichwörter der Autor:innen

Sema3Aactivated T cellsfatty acid metabolismhomeostasisimmunometabolismoxidative phosphorylationrheumatoid arthritis

Substanzen

Semaphorin-3AMechanistic Target of Rapamycin Complex 1Proto-Oncogene Proteins c-aktSEMA3A protein, human

Autor:innen und Institutionen

  • Proteomic Unit, Bnai Zion Medical Center, Haifa 3478403, Israel.
  • Rappaport Faculty of Medicine, Technion, Haifa 3478403, Israel.
  • Rheumatology Unit, Bnai Zion Medical Center, Haifa 3478403, Israel.
  • Rheumatology Out-Patient Clinic, "Lin"-Clalit Health Services (OMG), Haifa 3478403, Israel.

ORCID-Profile: Devy Zisman

Zitieren

APA

Mubariki, R., Eiza, N., Sabag, A. D., Keret, S., Rimar, D., Slobodin, G., Zisman, D., Toubi, E., & Vadasz, Z. (2025). Semaphorin3A Rewires CD4+ T-Cell Metabolism via AKT/mTORC1 Inhibition in Health and Rheumatoid Arthritis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262211160

Vancouver

Mubariki R, Eiza N, Sabag AD, Keret S, Rimar D, Slobodin G, et al. Semaphorin3A Rewires CD4+ T-Cell Metabolism via AKT/mTORC1 Inhibition in Health and Rheumatoid Arthritis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262211160

BibTeX
@article{Mubariki2025,
  author = {Mubariki, Raeda and Eiza, Nasren and Sabag, Adi D and Keret, Shiri and Rimar, Doron and Slobodin, Gleb and Zisman, Devy and Toubi, Elias and Vadasz, Zahava},
  title = {Semaphorin3A Rewires CD4+ T-Cell Metabolism via AKT/mTORC1 Inhibition in Health and Rheumatoid Arthritis},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262211160}
}
Kostenlos starten →